They suggested that there was no genetic relationship between the NOTCH3 gene and MS, but they also did not rule out the possibility that patients with an already altered NOTCH3 gene, as seen in CADASIL, could experience an increase in inflammation or alteration in their immune system functioning. This evidence concerns the gene NOTCH3 and myeloid sarcoma.